XML 61 R54.htm IDEA: XBRL DOCUMENT v3.24.3
Share-Based Compensation - Summary of the Option Unit Activity (Details)
$ / shares in Units, $ in Millions
 9 Months Ended
Sep. 30, 2024
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Weighted Average Remaining Contractual Term, Grants Vested 10 months 24 days
2021 Equity Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of units, grant outstanding beginning balance | shares 4,686,659
Number of grants, exercised | shares (252,784)
Number of grants, issued | shares 307,136
Number of grants, forfeited | shares (94,323)
Number of units, grant outstanding ending balance | shares 4,646,688
Number of grants, vested | shares 2,159,459
Number of grants, unvested | shares 2,487,229
Weighted average exercise price, grant outstanding beginning balance | $ / shares $ 13.61
Weighted average exercise price, grants issued | $ / shares 13.56
Weighted average exercise price, grants issued | $ / shares 17.55
Weighted average exercise price, forefeited | $ / shares 13.87
Weighted average exercise price, grant outstanding ending balance | $ / shares 13.87
Weighted average exercise price, grants vested | $ / shares 13.65
Weighted average exercise price, grants unvested | $ / shares $ 14.06
Weighted Average Remaining Contractual Term, Grants Outstanding 7 years
Weighted Average Remaining Contractual Term, Grants Vested 6 years 10 months 24 days
Aggregate Intrinsic Value, grants outstanding | $ $ 27.8
Aggregate Intrinsic Value, grants vested | $ $ 13.2
First Advantage Corporation [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of units, grant outstanding beginning balance | shares 1,915,252
Number of grants, exercised | shares (156,107)
Number of grants, forfeited | shares (16,978)
Number of units, grant outstanding ending balance | shares 1,742,167
Number of grants, vested | shares 726,095
Number of grants, unvested | shares 1,016,072
Weighted average exercise price, grant outstanding beginning balance | $ / shares $ 5.15
Weighted average exercise price, grants issued | $ / shares 5.23
Weighted average exercise price, forefeited | $ / shares 5.11
Weighted average exercise price, grant outstanding ending balance | $ / shares 5.15
Weighted average exercise price, grants vested | $ / shares 5.12
Weighted average exercise price, grants unvested | $ / shares $ 5.18
Weighted Average Remaining Contractual Term, Grants Outstanding 5 years 4 months 24 days
Weighted Average Remaining Contractual Term, Grants Vested 5 years 4 months 24 days
Aggregate Intrinsic Value, grants outstanding | $ $ 25.6
Aggregate Intrinsic Value, grants vested | $ $ 10.7